588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Olaparib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (48)
Olverembatinib Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P1/2	CCC (48)
Palifermin Acute Myeloid Leukemia	City of Hope Medical Center	P2	CCC (48)
Recombinant Human Thrombopoietin Acute Myeloid Leukemia	Huihan Wang	P3	CCC (48)
Rimiducid Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	CCC (48)
RVU120 Acute Myeloid Leukemia	Ryvu Therapeutics SA	P2	CCC (48)
Sonrotoclax Acute Myeloid Leukemia	Ruijin Hospital	P2	CCC (48)
u32 car-t Acute Myeloid Leukemia	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	P1/2	CCC (48)
Veliparib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CCC (48)
Vincristine Sulfate Acute Myeloid Leukemia	Children's Oncology Group	P2	CCC (48)
Xylitol Acute Myeloid Leukemia	Children's Oncology Group	P3	CCC (48)
ab8939 Acute Myeloid Leukemia	AB Science	P1/2	CC (47)
Anti-Siglec-6 Car-T Cell Therapy Acute Myeloid Leukemia	Xuzhou Medical University	P1/2	CC (47)
ard103 Acute Myeloid Leukemia	ARCE Therapeutics, Inc.	P1/2	CC (47)
Fosciclopirox Acute Myeloid Leukemia	CicloMed LLC	P1/2	CC (47)
gb3226 Acute Myeloid Leukemia	Galecto Biotech AB	P1/2	CC (47)
Hpc, Cord Blood Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CC (47)
Itacitinib Acute Myeloid Leukemia	City of Hope Medical Center	P2	CC (47)
np137 Acute Myeloid Leukemia	Centre Leon Berard	P1/2	CC (47)
Treg Cells Acute Myeloid Leukemia	Antonio Pierini	P2	CC (47)
Baricitinib Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	CC (46)
dvx201 Acute Myeloid Leukemia	Coeptis Therapeutics	P1	CC (46)
Flumatinib Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P2	CC (46)
Levetiracetam Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P2	CC (46)
Lilrb4 Star-T Acute Myeloid Leukemia	Hebei Yanda Ludaopei Hospital	P1	CC (46)
Lyt-200 Acute Myeloid Leukemia	PureTech	P1	CC (46)
Regorafenib Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (46)
tcb008 Acute Myeloid Leukemia	TC Biopharm	P2	CC (46)
Anti-Cd33 Car-Nk Cells Acute Myeloid Leukemia	Nationwide Children's Hospital	P1/2	CC (45)
Anti-Cll1 Cart Cells Acute Myeloid Leukemia	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	P1/2	CC (45)
bg1805 Acute Myeloid Leukemia	Guangzhou Bio-gene Technology Co., Ltd	P1/2	CC (45)
BN104 Acute Myeloid Leukemia	Chen Suning	P1/2	CC (45)
Car.70/Il15-Transduced Cb-Nk Cells Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (45)
cd123-car-nk cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1/2	CC (45)
CD123-CAR T Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
cd123-cd33 ccar t cells Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
cd33cart allogeneic Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd33cart autologous Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd7-specific car gene-engineered t cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
Dilanubicel Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2	CC (45)
Dual-Target Antigen-Selected Car-Nk Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Dubermatinib Acute Myeloid Leukemia	Uma Borate	P1/2	CC (45)
Eb-Select Single-Target Car-Nk Cells Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Enzomenib Acute Myeloid Leukemia	Sumitomo Pharma America, Inc.	P1/2	CC (45)
Mb-Dnpm1-Tcr.1 Acute Myeloid Leukemia	Miltenyi Biomedicine GmbH	P1/2	CC (45)
Orca-Q Acute Myeloid Leukemia	University of Florida	P1/2	CC (45)
rc1012 Acute Myeloid Leukemia	Guangdong Ruishun Biotech Co., Ltd	P1/2	CC (45)
Rivogenlecleucel Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	CC (45)
Sndx-5613 Acute Myeloid Leukemia	Syndax Pharmaceuticals	P1/2	CC (45)
Supcd7 Cart Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)

Showing 201 to 250 of 588 assets

PreviousPage 5 of 12Next